Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.

CONCLUSIONS: We identified aPS/PT antibodies as a determinant of denser and poorly lysable plasma fibrin clots formation in APS patients. The association of elevated aPS/PT antibodies with thromboembolism in APS could be at least in part mediated by prothrombotic clot properties. This article is protected by copyright. All rights reserved. PMID: 31220407 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31220407?dopt=Abstract

Source: Thrombosis and Haemostasis - June 19, 2019 Category: Hematology Authors: Zabczyk M, Celińska-Löwenhoff M, Plens K, Iwaniec T, Musiał J, Undas A Tags: J Thromb Haemost Source Type: research